AEON

AEON Biopharma, Inc. Class A Common Stock (AEON)

About AEON Biopharma, Inc. Class A Common Stock (AEON)

AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.

Details

Daily high

$0.26

Daily low

$0.24

Price at open

$0.25

52 Week High

$1.45

52 Week Low

$0.18

Market cap

12.1M

Dividend yield

Volume

656,901

Avg. volume

15.9M

P/E ratio

-.06

AEON Biopharma, Inc. Class A Common Stock News